Primary Safety Outcome as assessed by Incidence of serious adverse device effects 180 day follow-up [clinicaltrials_resource:0000f452bd285a79e2c3a23736438a7e]
Incidence of serious adverse device effects
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Primary Safety Outcome as assessed by Incidence of serious adverse device effects 180 day follow-up [clinicaltrials_resource:0000f452bd285a79e2c3a23736438a7e]
Incidence of serious adverse device effects
Bio2RDF identifier
0000f452bd285a79e2c3a23736438a7e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0000f452bd285a79e2c3a23736438a7e
measure [clinicaltrials_vocabulary:measure]
Primary Safety Outcome as assessed by Incidence of serious adverse device effects
time frame [clinicaltrials_vocabulary:time-frame]
180 day follow-up
description
Incidence of serious adverse device effects
identifier
clinicaltrials_resource:0000f452bd285a79e2c3a23736438a7e
title
Primary Safety Outcome as asse ...... vice effects 180 day follow-up
@en
type
label
Primary Safety Outcome as asse ...... 0f452bd285a79e2c3a23736438a7e]
@en